Related Articles from the A∙WOL Consortium
Reviews
Bockarie MJ, Taylor MJ, Gyapong JO. (2009) Current practices in the management of lymphatic filariasis. Expert Review of Anti-infective Therapy, 7 (5):595-605.
Hoerauf A. (2009) Mansonella perstans--the importance of an endosymbiont. New England Journal of Medicine, 361 (15):1502-4.
Pfarr KM, Debrah AY, Specht S, Hoerauf A. (2009) Filariasis and lymphoedema. Parasite Immunology, 31 (11):664-72.
Specht S, Hoerauf A. (2009) Filarial parasites in the postgenomic era. Expert Review of Anti-infective Therapy, 7 (2):189-92.
Specht S, Wanji S. (2009) New insights into the biology of filarial infections. Journal of Helminthology, 83 (2):199-202.
Taylor MJ, Awadzi K, Basáñez MG, Biritwum N, Boakye D, Boatin B, Bockarie M, Churcher TS, Debrah AY, Edwards G, Hoerauf A, Mand S, Matthews G, Osei-Atweneboana M, Prichard RK, Wanji S, Adjei O. (2009) Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasites & Vectors, 2 (1):7.
Weiner MP, Slatko B. (2009) Discover the microbes within! The HHMI Wolbachia Project. Biotechniques, 46 (7):497.
Hoerauf A. (2008) Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Current Opinion Infectious Disease, 21 (6):673-81.
Johnston KL, Taylor MJ. (2007) Wolbachia in filarial parasites: targets for filarial infection and disease control. Current Infectious Disease Reports, 9:55-9.
Kluxen G, Hoerauf A. (2007) Ocular onchocerciasis: a key role for Wolbachia. Ophthalmologe, 104 (10):860-5.
Pfarr KM, Hoerauf A. (2007) A niche for Wolbachia. Trends in Parasitology, 23 (1):5-7.
Hoerauf A. (2006) New strategies to combat filariasis. Expert Review of Anti-Infective Therapy, 4 (2):211-22.
Pfarr KM, Hoerauf A. (2006) Antibiotics which target the Wolbachia endosymbionts of filarial parasites: a new strategy for control of filariasis and amelioration of pathology. Mini Reviews in Medicinal Chemistry, 6 (2):203-10.
Foster JM, Zhang Y, Kumar S, Carlow CK. (2005) Mining nematode genome data for novel drug targets. Trends in Parasitology, 21 (3):101-4.
Pfarr KM, Hoerauf A. (2005) The annotated genome of Wolbachia from the filarial nematode Brugia malayi: what it means for progress in antifilarial medicine. PLoS Medicine, 2 (4):e110.
Taylor MJ, Bandi C, Hoerauf A. (2005) Wolbachia bacterial endosymbionts of filarial nematodes. Advances in Parasitology, 60: 245-84.
Hoerauf A. (2003) Control of filarial infections: not the beginning of the end, but more research is needed. Current Opinion Infectious Diseases,16 (5):403-10.
Hoerauf A, Büttner DW, Adjei O, Pearlman E. (2003) Onchocerciasis. BMJ, 326 (7382):207-10.
Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. (2003) Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends in Parasitology, 19 (11):516-22.
Taylor MJ. (2003) Wolbachia in the inflammatory pathogenesis of human filariasis. Annals of the New York Academy of Sciences, 990:444-9.
Hoerauf A, Adjei O, Büttner DW. (2002) Antibiotics for the treatment of onchocerciasis and other filarial infections. Current Opinion in Investigational Drugs, 3 (4):533-7.
Taylor MJ, Cross HF, Ford L, Makunde WH, Prasad GB, Bilo K. (2001) Wolbachia bacteria in filarial immunity and disease. Parasite Immunology, 23 (7):401-9.
Taylor MJ, Hoerauf A. (2001) A new approach to the treatment of filariasis. Current Opinion Infectious Diseases, 14 (6):727-31.
Taylor MJ, Bandi C, Hoerauf A, Lazdins J. (2000) Wolbachia bacteria of filarial nematodes: a target for control? Parasitology Today, 16 (5):179-80.
Taylor MJ, Hoerauf A. (1999) Wolbachia bacteria of filarial nematodes. Parasitology Today 15 (11):437-42.